# Antibiotic Prophylaxis for Neurogenic Bladder Botox

> **NCT04791579** · PHASE2 · RECRUITING · sponsor: **University of Alberta** · enrollment: 160 (estimated)

## Conditions studied

- Neurogenic Bladder
- Post-operative Urinary Tract Infections

## Interventions

- **DRUG:** Ciprofloxacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04791579
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04791579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04791579, "Antibiotic Prophylaxis for Neurogenic Bladder Botox". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04791579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*